Company: EDSA
Filing Date: 2025-09-09
Form Type: 424B5
Source: 0001171843-25-005799
Chunk: 7

Company: Edesa Biotech, Inc.
Filing Date: 2025-09-09
Form: 424B5
Chunk 7
---
in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking
statements. We caution you therefore that you should not rely on any of these forward-looking statements as statements of historical fact
or as guarantees or assurances of future performance. You should understand that many important factors, in addition to those discussed
in this prospectus supplement, the accompanying prospectus and any documents we incorporate by reference, could cause our results to differ
materially from those expressed in the forward-looking statements. Important factors that could cause actual results to differ materially
from those in the forward-looking statements include changes in local, regional, national, or global political, economic, business, competitive,
market (supply and demand) and regulatory conditions and the following:

| · | our ability to obtain funding for our operations; |

| · | our estimates regarding our expenses, revenues, anticipated capital requirements and our needs for additional financing; |

| · | the timing of the commencement, progress and receipt of data from any of our preclinical and clinical trials; |

| · | the expected results of any preclinical or clinical trial and the impact on the likelihood or timing of any regulatory approval; |

| · | the therapeutic benefits, effectiveness and safety of our product candidates; |

| · | the timing or likelihood of regulatory filings and approvals; |

| · | changes in our strategy or development plans; |

| · | the volatility of our common share price; |

| · | the rate and degree of market acceptance and clinical utility of any future products; |

| · | the effect of competition; |

| · | our ability to comply with the continued listing requirements of the Nasdaq Capital Market; |

| · | our ability to protect our intellectual property as well as comply with the terms of license agreements with third parties; |

| · | our ability to identify, develop and commercialize additional products or product candidates; |

| · | reliance on key personnel; |

| · | general changes in economic or business conditions; and |

| S-3 |

Other sections of this prospectus supplement,
the accompanying prospectus and any documents we incorporate by reference describe additional risk factors that could adversely impact
our business and financial performance. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from
time to time, and it is not possible for our management to predict all risk factors and uncertainties, nor are we able to assess the impact
of all of these risk factors on our business or the extent to which any risk factor